Vaccine Safety and Adverse Event Reports |
|
|
Clinical Trial: A Study to Evaluate the Safety, Immune Response, and Efficacy of an Investigational Vaccine in Women
This study is currently recruiting patients.
|
Purpose
This study is to assess the tolerability and efficacy of a vaccine being evaluated to reduce the incidence of human papillomavirus (HPV) infection and disease (external genital warts and vulvar, vaginal, and cervical cancer) in women.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Healthy Papillomavirus Infection | Vaccine: Investigational Vaccine | Phase II Phase III |
MedlinePlus related topics: Viral Infections
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Eligibility
Ages Eligible for Study: 24 Years - 45 Years, Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
- No history of HPV infection, surgical treatment to the cervix, or gential warts
Location and Contact Information
Alabama
Call for Information, Birmingham, Alabama, 35233, United States; No longer recruiting
California
Call for Information, Davis, California, 95616, United States; No longer recruiting
Call for Information, Colton, California, 92324, United States; No longer recruiting
Call for Information, Fountain Valley, California, 92708, United States; No longer recruiting
Colorado
Call for Information, Boulder, Colorado, 80027, United States; No longer recruiting
Florida
Call for Information, Tampa, Florida, 33607, United States; No longer recruiting
Georgia
Call for Information, Augusta, Georgia, 30912, United States; No longer recruiting
Illinois
Call for Information, Champaign, Illinois, 61820, United States; No longer recruiting
Indiana
Call for Information, Indianapolis, Indiana, 46202-5124, United States; No longer recruiting
Kentucky
Call for Information, Bardstown, Kentucky, 40004, United States; No longer recruiting
New York
Call for Information, Stony Brook, New York, 11794-8091, United States; No longer recruiting
North Carolina
Call for Information, Chapel Hill, North Carolina, 27514, United States; No longer recruiting
Pennsylvania
Call for International Site Information, Horsham, Pennsylvania, 19044, United States; Recruiting
Call for Information, Trexlertown, Pennsylvania, 18087-0060, United States; No longer recruiting
Call for Information, Philadelphia, Pennsylvania, 19114, United States; No longer recruiting
Virginia
Call for Information, Richmond, Virginia, 23226, United States; No longer recruiting
More Information
Record last reviewed: March 2005
Last Updated: March 21, 2005
Record first received: August 25, 2004
ClinicalTrials.gov Identifier: NCT00090220
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


